MDMA use and neurocognition: a meta-analytic review

Psychopharmacology (Berl). 2007 Jan;189(4):531-7. doi: 10.1007/s00213-006-0601-2. Epub 2006 Nov 3.

Abstract

Rationale: To determine the association between MDMA misuse and neurocognition using meta-analysis.

Objective: Separate analyses were conducted based on two sets of inclusion/exclusion criteria. A relatively stringent set required that the subjects be matched on important moderator variables, whereas the other did not. The study participants' performance in the following neurocognitive domains was reviewed: attention/concentration, verbal and nonverbal learning and memory, psychomotor speed and executive systems functioning.

Results: In the 11 studies meeting the relatively stringent inclusion/exclusion criteria for this review, MDMA use was associated with neurocognitive deficits in each domain. Similarly, in the 23 studies meeting the relatively lenient inclusion/exclusion criteria for this review, MDMA use was associated with neurocognitive deficits in each domain. Small to medium effect sizes were generally observed. A comparison of the effect sizes across the two sets of analyses did not reveal significant differences.

Conclusions: The findings from this review reveal that MDMA use is associated with neurocognitive deficits. The implications of these findings are discussed.

Publication types

  • Meta-Analysis
  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Amphetamine-Related Disorders / etiology*
  • Amphetamine-Related Disorders / psychology
  • Attention / drug effects
  • Cognition / drug effects*
  • Cognition Disorders / chemically induced*
  • Cognition Disorders / psychology
  • Hallucinogens / adverse effects*
  • Humans
  • Learning / drug effects
  • Memory / drug effects
  • N-Methyl-3,4-methylenedioxyamphetamine / adverse effects*
  • Problem Solving / drug effects
  • Psychomotor Performance / drug effects

Substances

  • Hallucinogens
  • N-Methyl-3,4-methylenedioxyamphetamine